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Summary
The respiratory burst oxidase of phagocytes and B lymphocytes is a multicomponent enzyme
that catalyzes the one-electron reduction of oxygen by NADPH. It is responsible for the 02 -
production that occurs when these cells are exposed to phorbol 12-myristate 13-acetate or physiologic
stimuli, such as phagocytosis in phagocytes or cross-linking of surface immunoglobulin in B
lymphocytes. The activity of this enzyme is greatly diminishedor absent in patients with chronic
granulomatous disease (CGD), an inherited disorder characterized by a severe defect in host defense
against bacteria and fungi. In every CGD patient studied so far, an abnormality has been found
in a gene encoding one of the four components of the respiratory burst oxidase: the membrane
proteins p22Ph- or gp91Ph- which together form the cytochrome b558 protein, or the cytosolic
proteins p47Ph- or p67Ph-. Autosomal recessive cytochrome-negative CGD (A22° CGD) is
associated with mutations in the gene coding for p220-. We report here that the capacity for
02 - production and cytochrome b558 protein expression were restored to Epstein-Barr
virus-transformed B lymphocytes from two A22° CGD patients by transfection with an
expression plasmid containing a p22ph- cDNA. No detectable 02 - was generated by
untransfected p220--deficient lymphocytes. The genetic reconstitution of the respiratory burst
in A22° CGD B lymphocytes by transfer of the wild-type p22ph- cDNA represents a further
step towards somatic gene therapy for this subgroup of A22° CGD. This system will also be
useful for expression of genetically engineeredmutant p22Ph- proteins in intact cells, facilitating
the structure-function analysis of cytochrome b558.
T
he 02- -forming NADPH oxidase of phagocytes (1)
and B lymphocytes (2-4), also called the respiratoryburst
oxidase, is a multicomponent, membrane-bound enzyme that
catalyzes the one-electron reduction of oxygen to 02 - (1):
2 02 + NADPH - 2 02 - + NADP+ + H+ . In vesting
phagocytesand B lymphocytes, the enzyme is not active, but
acquires catalytic activity when the cells are stimulated by
appropriate agents such as the protein kinase C activator PMA,
or physiologically by phagocytosis (1) in case of phagocytes,
and by cross-linking of surface Ig in B lymphocytes (3).
The respiratory burst oxidase plays a critical role in the
generation of a complex group of reactive oxidants, including
free radicals and oxidized halogens. In phagocytes, these ox-
idants serve as potent microbicidal agents (5). The role of
02- formation in B lymphocytes (2-4) which are non-
phagocytic, noncytotoxic cells, is not yet defined. Oxidase
activity in B lymphocytes is about 10% of that seen in phago-
cytes, as determined by 02- generation and by complemen-
tation assays in a cell-free oxidase-activating system (2-4, 6).
In the resting cell, oxidase components are distributed
between the cytosol and the plasma membrane, but upon ac-
tivation, the cytosolic components move to the plasma mem-
brane to assemble the active enzyme (7, 8). Oxidase com-
ponents that are always found in the membrane include a
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b558, and an associated Ras-related low molecular weight
G protein, rap1A (also designated Krev-1) (9-11). The cyto-
chrome, postulated to be the terminal electron carrier in the
electron pathway from NADPH to oxygen, is an oligomeric
heme- and flavin-containing glycoprotein composed of the
polypeptides p220- and gp91Ph°x (9, 12-14). raplA has been
postulated as an oxidase component since it copurifies with
cytochrome b558 (11), however, its function within the oxi-
dase complex has not yet been elucidated. The cytosolic oxi-
dase components include the proteins p47ph°x and p67Ph°x,
both of which have been unequivocally established as essen-
tial elements of the oxidase (15) and one or both of the cyto-
solic GTP-binding proteins racl or rac2, each of which has
been reported to support oxidase activity in a cell-free system
(16, 17). During the cell activation process, all of these pro-
teins migrate from the cytoplasm to the membrane.
Defective activity of the respiratory burst oxidase is the
cause of an inherited disorder known as chronic granuloma-
tous disease (CGD)t (18). In this condition, phagocytes pro-
duce little or no OZ- , and as a consequence, affected patients
suffer from recurrent life-threatening infections. In all CGD
patients studied to date, the abnormality in oxidase activity
has been attributed to a defect in one of the four compo-
nents: the a (p220-) or 0 (gpglph-) subunit of cytochrome
b558, p47Ph°x, or p67ph°x. All of these oxidase components
have been cloned (19-22). However, only the cytosolic pro-
teins p47ph- and p67Phox have so far been expressed as func-
tional proteins in bacterial fusion constructs and in the
baculovirus expression system (21, 23, 24). Recombinant
p47Ph°x and p67A- have been shown to restore oxidase ac-
tivity to p470°x- or p67Ph°x-deficient cytoplasm in the cell-
free, oxidase-activating system (23, 24), and transfection of
an expression vector directing p47Ph°x synthesis has been
shown to restore oxidase activity to p47Ph--deficient B lym-
phocyte lines (25, 26, 27).
Partially purified human neutrophil rytochrome b558 has
been reported to reconstitute the defective oxidase activity
of cytochrome-deficient CGD neutrophils in a cell-free oxi-
dase activation system (28). However, attempts at expression
ofrecombinant rytochrome b558 or its subunits in COS cells
(29) and baculovirus expression systems (30) have met with
limited success, and functionally active, recombinant ryto-
chrome has thus far not been obtained. Cytochrome b558
is a structurally unusual rytochrome and shares only modest
partial homology with other cytochromes. Furthermore, in
CGD patients with mutations in one rytochrome subunit,
the level of the unaffected subunit protein is generally greatly
reduced (20, 31), suggestingthat the single subunits are not
stable in the absence of heterodimer formation. Mutations
of the p22?h- gene have been identified in patients with au-
tosomal, rytochrome-negative (A22°) CGD (29), and mu-
tations of the gene for gp91Ph°x are found in patients with
X-linked rytochrome-negative (X91°) CGD (19). However,





the causal nature of the genetic defects in these subgroups
of CGD has not been shown formally because of a lack of
an expression system for generation of functionally active
recombinant p220- and gp9lph°x. Structure-function studies
ofthe cytochrome b558 have also been hampered by the lack
of a suitable system for expression of recombinant derivatives
of p22Ph°x and gp9lph°x, as altered by site-directed muta-
genesis.
In this paper, we report the reconstitution of oxidase ac-
tivity in intact autosomal cytochrome-negative CGD (A22°
CGD)-derived B lymphocyte cell linesby stable transfection
with an expression vector containing a cDNA that encodes
p22phox.
Materials and Methods
Autosomal Cytochrome-negative CGD (A22° CGD) Patients.
CGD patients were diagnosed as autosomal cytochrome-negative
(A22°) CGD according to established clinical and laboratory
criteria (32) . The p22 gene of patient A22°:1 was sequenced and
exhibits a nucleotide change (C-382 - A) predictinga nonconser-
vative amino acid change (Ser-118 -+ Arg) in the mature p22phox
protein (29). Patient A22°:2 was also characterized previously
as autosomal recessive cytochrome negative CGD (33), and is un-
related to patient A22°:1.
Cell Lines and Medium.
￿
EBVtransformed B cell lines from
A22° CGD patients were established by transformation of PBMC
with EBV . Briefly, after obtaining informed consent, mononuclear
cells were isolated from samples ofvenous blood and cultured with
supernatant of the B95-8 marmoset B cell line containing EBV
virions, using RPMI 1640 medium supplemented with 20% heat-
inactivated FCS (Hyclone Laboratories, Logan, UT), the antibi-
otics penicillin, streptomycin, and fungizone, and buffered to pH
7.2. Cellswere kept in a humidified incubator at 37°C gassed with
ambient air plus 5% COZ. Continuously growing EBV
transformed cell lines were obtained after 5-6 wk and were carried
further in RPMI 1640 medium supplemented with 10% heat-
inactivated FCS, the antibiotics penicillin, streptomycin, and
ciprofloxacin, and buffered with 20 mM Hepes to pH 7.2 (3). Via-
bility of EBVtransformed cell lines was routinely >90% by trypan
blue exclusion test. EBVtransformed B lymphoblast lines from pa-
tients with X-linked CGD (X91°-CGD B cell lines) and from
normal individuals (wild-type EBV B cell lines) were derived in
an analogous fashion.
The human PLB-985 myelomonoblastic cell line has been de-
scribed earlier (34). To obtain granulocyte-like forms, PLB-985 cells
were exposed to 60 mM dimethylformamide for 6 d. The levels
of cytochrome b558 in these induced cells is about 50% of that
seen in normal peripheralblood neutrophils (our unpublished ob-
servation).
Construction ofExpression Vector pEBOp22Ph-.
￿
The expression
vector pEBOp22Ph- was constructed by inserting a full-length
p22P' cDNA into the episomal expression vector pEBOpLPP. pE-
BOpLPP, a 10.6-kb plasmid constructed from portions of the four
plasmids pcDV, pL, pUC19, and EBOpSVNeo (35) was from R.
Margolskee (Roche Research Institute, Nutley, NJ) and F. V Chisari
(The Scripps Research Institute). The vector contains the following
functional units: a pBR322 origin, a a-lactamase-gene, an EBNA-1
gene driven by a SV40 late promoter, a gene encoding hygromycin
phosphotransferase driven by an SV40 earlypromoter, an SV401ate-
region intervening sequence, the SV40 origin of replication oriP,
and a polylinker region containing unique sites 5'-Sacl-HindIII-
NADPH Oxidase Activity in A22° CGDXbal-SaII-NotI-KpnI-3' theinsert of which is driven by a second
SV40 early promoter.
A full-length clone of p22ph- cDNA (20) was subcloned into
the EcoRI site of pGEM9 (Promega, Madison, WI). The700-bp
insert containing p22Ph- cDNA was then directionally cloned in
thesenseorientation into the HindIII-Sstl site ofpEBOpLPP. The
final construct, pEBOp22Ph-, was amplified in Escherichia coli
DH5ot and purified by alkaline lysis and cesium chloride banding
for transfection of cell lines. Where not otherwise indicated, mo-
leculargenetic manipulations were performedas describedby Sam-
brook et al. (36) .
Transfection and Selection.
￿
pEBOp22P' plasmid DNA was in-
troduced into A220 CGD B lymphocyte cell lines by electropora-
tion (37). Forthis, cell lines were kept in logarithmic growth phase
by splitting them 1:2 forthree consecutive days. Before electropo-
ration, cells were transferred into serum-free RPMI 1640 medium
supplemented with 1 mM glucose and 0.1 mM dithiothreitol to
give a final density of 20 x 106/ml. 500 Al cell suspension (10'
cells) were mixedgently with 10 Ag plasmidDNA in an electropo-
ration cuvette (0.4 cm electrode distance, BioRad Laboratories, Cam-
bridge, MA) and immediately subjected to electroporation at 200
V and 960 pF using a gene pulser (BioRad Laboratories). These
manipulations were done at ambient temperature under sterile con-
ditions. Transfection efficiency wasabout 5% using(3-galactosidase
as reporter gene. Immediately after the electroporation pulse, cells
were transferred to 10 ml of complete culture medium. After 48
h of culture, selection of transfectants was started by adding
hygromycin at 50 wg/ml. Selection of transfectants was complete
after4wk ofculture in hygromycin; selected cells were maintained
at 25 Rg/mlhygromycin.Viability oftransfectant lineswas80-90%
as assessed by trypan blue exclusion.
Isolation andAnalysis ofRNA.
￿
Total RNA was isolated from
B cell lines by the acid guanidinium thiocyanate method (38).
Northern blot analysis with 31p-labeled cDNA probes was per-
formed essentially aspreviously described(29). Briefly, sampleswere
electrophoresed on denaturing formaldehyde-agarose gels, trans-
ferred to nylonmembranes(Magnagraph; Micron Separations, West-
boro, MA), hybridized with radiolabeled probes using conditions
suggestedby themanufacturer, andwashed underhigh stringency
conditions. The p22Ph°x probe was a full-length cDNA (20) . The
human /3-actin cDNA was obtained from C. Srivastava (Indiana
State University School of Medicine, Indianapolis, IN).
Immunoblot Analysis ofProtein Expression.
￿
Triton X-100extracts
of whole cells (19) and of cytosolic and membrane fractions iso-
lated from sonicated cells (8) were prepared for immunoblot anal-
ysis as described (19). Ab bindingwasdetected by achemilumines-
cent method using a horseradish peroxidase-conjugated second Ab
(Amersham Corp., Arlington Heights, IL). The p22Ph- Ab was
affinity purified from rabbits immunizedwith a synthetic peptide
derived from p2V'- sequence (39). The gp9lP'- Ab was a mouse
mAb raised to purified cytochrome b (31), kindly provided by Dr.
Dirk Roos (The Netherlands RedCross Central Laboratory, Am-
sterdam, The Netherlands) .
Chemiluminescence Monitoring ofPeroxide Generation by B Cells.
Cells were transferred from culture medium into phenol red-free
MEM(GIBCO BRL, Gaithersburg, MD), supplemented with BSA
(100 ug/ml) and buffered with 5 mM Hepes, pH 7.2, to give a
final cell density of 5 x 106/ml. Luminol (100 AM final concen-
tration) and horseradish peroxidase (10 U/ml) were added forlu-
minescent detection of hydrogen peroxide (40). A 200-Al cell sus-
pension, containing 106 cells, was placed into the wells of a white
opaque microtiter plate (DynatechLaboratories Inc., Chantilly, VA).




tegrals or kinetically by repeated recordings of 15- or 30-min in-
tegralsby single photon imagingin acamera luminometer (Argus
100; HamamatsuPhotonic SystemsCorp., Bridgewater, NJ) ther-
mostatted to 37°C as described earlier (41).
Nitroblue Tetrazolium (NBT) Reduction.
￿
NBT reductionwasused
to estimate thefrequency of superoxide-generating cellsas described
earlier (4). Briefly, cells at adensity of 2 x 106/ml in RPMI 1640
medium containing 10% FCS were stimulated at 37°Cwith PMA
(100 ng/ml) in the presence of 1 mg/ml NBT
The reaction was stopped by the addition of an equal volume
of ice-cold 2% paraformaldehyde andthefrequency of NBTpositive
(blue) cells determined by light microscopy.
Reagents.
￿
NBT, Luminol, glucose, dithiothreitol, PMA, horse-
radish peroxidase, and superoxide dismutase were purchasedfrom
Sigma Chemical Co. (St. Louis, MO). Protein A-bearing staphy-
lococci (Pansorbin) and hygromycin were obtained from
Calbiochem-Novabiochem Corp. (La Jolla, CA).
Results
Northern Blot Analysis ofp22Phox.
￿
To verify the effective-
ness of transcription from the plasmid pEBOp22Ph- trans-
fected into B cell lines, Northern blots were performedusing
a p22Ph°x probe. Normal wild-type EBV B cells contained
p22ph- mRNA of the expected size (0.9 kb), which was
barely detectable in both A22° CGD-derived EBV B cell
lines. In contrast, after transfection with pEBOp22Ph-, both
A22° CGD-derived EBV B cell lines contained an abundant
1.6-kb plasmid-derived p22Ph- mRNA species in addition to
the endogenous 0.9-kb transcript (Fig. 1).
Immunoblot Analysis of Cytochrome b558 Subunit Proteins.
Next, cellular expression of thep22p
h- cytochrome subunit
was investigated by immunoblotting. Granulocyte-induced
PLB-985 cells, wild-type EBV B cell lines and, to a much
lesser extent, X91° CGD-derived EBV B cell lines expressed
p22ph- immunoreactive protein. In contrast, p22ph- im-
munoreactive protein was undetectable in both parental
A22° CGD lines. However, correlating with the abundant
production of plasmid-derived p22Ph- mRNA, A22° CGD
lines transfected with EBO-p22Ph- contained readily detect-
able p22ph- protein, at levels equal to or even exceeding
those seen in wild-type EBV B cell lines (Fig. 2, top). The
p22Phox in the wild-type B cell line and the A22° line trans-
fected with EBO-p22Phox was localized to the membrane
fraction (Fig. 2, top), as expected.
It has been noted previously that A22° CGD neutro-
phils also lack the glycosylated large cytochrome subunit,
gp9lPhox, apparently because of a lack of stabilizing interac-
tion with p22p
h- (29, 42). It was therefore of interest to de-
termine expression of gpglphox in A22° CGD-derived B cell
lines before and after correction of p22ph- expression by
transfection. Using a mAb raised to purified cytochrome b
(31), the gp91P
h- detected in wild-type B cell lines appeared
as adiffuse band rangingfrom about 55 to 95 kD, in contrast
to its appearance as a band centered at about 90-110 kD in
granulocyte-induced PLB-985 cells (Fig. 2, bottom) and pe-
ripheral blood neutrophils (19). This finding mayreflectdiffer-
ences in glycosylation between B cells and myeloid cells.
A22° CGD-derived B cell lines contained a membrane-Figure 1 .
￿
Northern blot of total cellularRNA derived from control
and transfected B lymphoblast lines . RNA was isolated from a wild-type
B cell line and B cell lines derived from A220 CGD patients 1 and 2 be-
fore and after transfection with the pEBOp22 expression plasmid . After
denaturing gel electrophoresis, RNAs were transferred to a nylon mem-
brane and hybridized with a 32p-labeled full-length cDNA probe for
p22Pb- (top), and subsequently with a labeled cDNA probe for actin
(bottom) . The marks note the positions of the endogenous p22pb°x (0.9
kb) and actin (2.1 kb) transcripts, as well as the p22pb- transcript derived
from the pEBOp22 construct (1.6 kb) .
associated immunoreactive protein of about 55 kD, which
was absent in an X91° B cell line, that may represent un-
glycosylated gp9lph- (Fig . 2, bottom) . After transfection with
EBO-p220-, both A22° CGD-derived B cell lines contained
forms of gpglphox ranging from about 55 to 100 kD, now
resembling the wild-type B cells (Fig. 2, bottom) . All of the
EBV B cell lines examined had a prominent band of about
100 Kd (Fig. 2, bottom), which localized to the cytosolic frac-
tion in sonicated cells . As this species was also present in a
cell line derived from a patient with X91° CGD (Fig. 2,
bottom), it is likely to represent a cross-reactive protein .
Transfection with pEBOp22ph°x Restores Oxidase Activity .
Before transfection with p22ph°x, both A22° CGD-derived
B cell lines failed to generate chemiluminescence and to re-
duce NBT in response to stimulation with either phorbol




Immunoblot of protein extracts isolated from myeloid and
B lymphoblast cell lines. B cell lines and granulocyte-induced PLB-985
were solubilized and analyzed for expression of p22Ph- (top) or gp9lph-
(bottom) using Abs raised to these cytochrome subunits. Membrane and
cytosolic fractions were also analyzed for some of the B cell lines. Each
lane of whole cell extract (Total extract) was loaded with 25 Rg of protein,
except for granulocyte-induced PLB-985 cells which contained only 5 hg
of protein . 15 and 10 Fcg were loaded for extracts prepared from cytosol
and membrane fractions, respectively. Cell lines analyzed were a B cell
line from a normal individual (WT), B cell lines from the 2 A220 CGD
patients before (A220:1 and A220:2) and after transfection with the
pEBOp22 expression plasmid (A220:1 + p22 andA220:2 + p22), a B
cell line from a patient with cytochrome-negative X-linked CGD (X910),
and the myeloid PLB-985 cell line, induced to differentiate into granulo-
cytic forms with dimethylformamide .
A (Table 1 and Fig. 3) . This inability to perform an oxidative
burst is in line with previous reports on the missing oxidase
activity of CGD-derived, EBV-transformed B cell lines (2) .
In contrast, the transfectants A220:1/pEBOp22 and
A220:2/pEBOp22 clearly possessed oxidase activity (Fig. 3
and Table 1) . This was evident both in the NBT reduc-
tion assay which is sensitive to superoxide, and in the chemi-
luminescence assay which detects hydrogen peroxide. The fre-
quency of NBT-positive cells among PMA-stimulated
A220:2/PEBOp22 was about double that of PMA-stimu-
lated A220:1/pEBOp22 cells, and in parallel, A220:2/
pEBOp22 cells exhibited higher chemiluminescence than
A220:1/pEBOp22 . Interestingly, in addition to phorbol ester
PMA, pEBOp22-transfected A22° CGD-derived B cell lines
also responded with oxidase activity in response to cross-
linking of surface Ig by protein A (Fig. 3) which represents
a more physiologic and receptor-mediated stimulus ofNADPH
oxidase in normal EBV B cell lines (3) . The relative level of
oxidase activity of the A22° pEBOp22 transfectants (as mea-
sured both by NBT reduction and chemiluminescence) was
within the range of oxidase activity seen in a panel ofnormal
P22PF°" Transfection Restores NADPH Oxidase Activity in A220 CGDTable 1.
￿
NBT Reduction by A220 CGDB Cell Lines before
and after Transfection with pEBOp22P'-
' 106 cells in 500 Al RPMI/10% FCS with 1 mg/ml NBTwere stimu-
lated with 100 ng/ml PMA and incubated at 37°C . The reaction was
stopped with ice-cold 2% paraformaldehyde/PBS and the frequency of
NBT-positive (blue) cells determined by light microscopy from a mini-
mum of 500 cells counted .
t Superoxide dismutase, 100 jug/ml .
SSOD boiled for 15 min, 100 p.g/ml .




EBVB cell lines (datanot shown) . Transfection ofwild-type,
oxidase-competent EBV B cell lines with pEBOp22Ph- had
no effect on oxidase activity (data not shown) .
Discussion
Mutations in the p22yy°x gene, which codes for the small
subunit of cytochrome b558, have previously been identified
in several patients with autosomalcytochrome-negativeCGD
(29) . However, in the absence ofan expression and assay system
for natural or mutant cytochrome b558, it could not be for-
mallydemonstrated that the missense variants result in a defec-
tive p22Ph°x cytochrome subunit . Here, we made use of the
fact that the NADPH oxidase of phagocytes is also present
in B lymphocytes (2-4) and that EBV-transformed B lym-
phocyte cell lines generated from CGD patients share the
genetic defects apparent in the patients' phagocytes (2). Trans-
fection of A220 CGD-derived B cell lines with an expres-
sion vector containing a wild-type p22Ph°z cDNA led to
production of recombinant p22Ph°x protein, "rescue" of the
large subunit of cytochrome b558, and most importantly,
to restoration of the capacity to generate an oxidative burst
in response to defined stimuli . Restitution of p22ph°x expres-
sion and oxidase activity was observed in cell lines derived
from two unrelated A22° CGD patients . These data repre-
sent the first formal demonstration that the respiratory burst
in CGD patients with p220°x gene defects can be recon-
stituted by expression of wild-type p220- . These results also
underscore the importance of cytochrome b558 expression
for intact oxidase function . We (25) and other authors (26,
27) have previously used similar approaches to functionally
correct genetic defects in EBV-transformedB cell linesfrom
p47PF--deficient patients . The ability to achieve genetic
Figure 3 .
￿
Chemiluminescence of A220CGD B cell lines
before and after transfection with pEBOp2Zp6-. (Top) In-
tegrated chemiluminescence. 106 cells in 250 pl phenol
red-freeMEMwere placed in wells ofa white opaque micro-
titer plate in the presence of 100AM Luminol and 10 pg/ml
horseradish peroxidase. After addition of stimuli (Pansorbin
[PSI, 1 mg/ml;PMA, 100 ng/ml), chemiluminescence was
accumulated for4h simultaneously from all samples by single
photon imaging. (No cells) Mean chemiluminescence accu-
mulated over four empty wells = camera background. Addi-
tion of catalase (50 Rg/ml), but not of irrelevant protein
(human serum albumin) abolished these chemiluminescence
responses. One representative experiment of five is shown,
and data are means of triplicates with SD <15%. (Bottom)
Kinetic chemiluminescence measurement. Native A220:2 and
pEBOp220--transfected A22o:2/pEBOp22 cells were each
set up in duplicates as in the upper panel . After stimulation
with PMA (100 ng/ml), chemiluminescence was repeatedly
accumulated over 15-minintervals. Data points represent mea-







A220:1 - 30 0.2'
- 60 1 .06
A220:1/pEBOp22 - 30 1 .75
- 60 8 .08
SOD# 60 2.2
Boiled SODS 60 7.94
HSAII 60 8.2
A22o:2 - 30 0.3
- 60 2.5
A220:2/pEBOp22 - 30 3.9
- 60 23.1
SOD 60 3.2
Boiled SOD 60 21 .2
HSA 60 22 .2reconstitution of CGD B cell lines is a useful in vitro model
in which to develop an experimental framework for somatic
gene therapy of this life-threatening disease.
Although the cDNAs for the p22Ph°x and gpglphox
subunits of cytochrome b558 have been isolated some years
ago (19, 20), thefunctional organization ofthis heterodimer
has been largely uncharacterized. Thep220--deficient B cell
lines derived from A220 CGD patients provide a useful
whole cell model for expression of recombinant p22Ph- and
for evaluation of the effects of specific modifications in
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p22Ph°x as introduced by site-directed mutagenesis. Su-
peroxide and derived reactive oxygen species not only serve
useful microbicidal functions, butcan also cause serious tissue
damage. The excessive generation of phagocyte-derived ox-
idants has been implicated in the pathogenesis of a wide va-
riety of inflammatory conditions (5, 43). Definition of crit-
ical functional domains within cytochrome b558 may aid in
the rational design of antiinflammatory agents that specifically
interfere with superoxide formation.
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